CH

Glycovaxyn Ag


USPTO Granted Patents = 6

% Expired Patents = 16.7



Forward Citations = 44

Loading Chart...
Loading Chart...

9 inventors (with patents filed for the assignee):

goldMedal Michael Wacker (5 out of 13 patents)

silverMedal Michael L Wetter (4 out of 17 patents)

bronzeMedal Michael T Kowarik (4 out of 37 patents)

4.  Charles Waechter (2 out of 2 patents)

5.  Manuela Mally (1 out of 15 patents)

6.  Fabiana Fernandez (1 out of 5 patents)

7.  Veronica Gambillara (1 out of 5 patents)

8.  Stefan Jochen Kemmler (1 out of 19 patents)

9.  Micha Andres Häuptle (1 out of 7 patents)

10.  Christiane Marie-Paule Simone Jeanne Feron (3 patents)

11.  Julien Laurent Quebatte (2 patents)

12.  Amirreza Faridmoayer (2 patents)

13.  Benjamin G Davis (6 patents)

14.  Balakumar Vijayakrishnan (1 patent)

15.  Feng Lui (0 patent)


6 patents:

Company Overview
Glycovaxyn Ag is a biotechnology company focused on developing innovative vaccines to prevent infectious diseases. Their technology platform leverages glycoconjugate vaccines to create effective and safe solutions for a wide range of pathogens. With a strong emphasis on research and development, Glycovaxyn aims to address global health challenges through cutting-edge immunization strategies.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

6 Patents

#100 in

#1,483 in Switzerland

CH
CH
Forward Citations = 44

9 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Glycovaxyn Ag. Retrieved from https://idiyas.com/company/glycovaxyn-ag

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…